INSTITUT PASTEUR DE LILLE FONDATION
- Country
- France
- Type
- Beneficiary
- Website
- www.pasteur-lille.fr
- Grants received
- 19
Funding record
- 19 grants on record
- €8,466,900.08 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
5 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- Department of Health
- ACADEMISCH ZIEKENHUIS LEIDEN
- STATENS SERUM INSTITUT
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- INSTITUT PASTEUR
- ISTITUTO SUPERIORE DI SANITA
- LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
Calls from this organisation
No published calls from this organisation.
Grants received
- Biological Factors in Fleas: Determinants of Physiology and Pathogen Transmission
- Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity
- FLAGELLIN AEROSOL THERAPY AS AN IMMUNOMODULATORY ADJUNCT TO THE ANTIBIOTIC TREATMENT OF DRUG-RESISTANT BACTERIAL PNEUMONIA
- EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS
- Bile acid, immune-metabolism, lipid and glucose homeostasis
- PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910
- Common mechanisms and pathways in Stroke and Alzheimer's disease.
- TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development
- A common European approach to the regulatory testing of nanomaterials
- SYSTEMS BIOLOGY OF PATHWAYS INVOLVING BRAIN AGEING
- A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol
- Biomarker for Cardiovascular Risk Assessment in Europe
- A Novel Filtration Technology Targeted at Enhancing the European Healthcare System´s Efforts in Restraining the Spread of the Hospital Infection
- The targeted development of a new generation Vaccine for Schistosomiasis
- Discovery and preclinical development of new generation tuberculosis vaccines
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.